Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

20.05.2024

4 Alzheimer Dis Assoc Disord
22 Alzheimers Dement
2 Am J Geriatr Psychiatry
3 Ann Neurol
1 BMC Neurosci
3 Brain
1 Brain Res
1 Exp Gerontol
1 Exp Neurol
13 J Alzheimers Dis
1 J Am Geriatr Soc
1 J Neurosci
1 Lancet Neurol
1 Nat Med
1 Nat Rev Neurol
1 Neurobiol Dis
1 Neurosci Lett
2 PLoS One



    Alzheimer Dis Assoc Disord

  1. MORIN P, Aguilar BJ, Berlowitz D, Zhang R, et al
    Clinical Characterization of Veterans With Alzheimer Disease by Disease Severity in the United States.
    Alzheimer Dis Assoc Disord. 2024 May 17. doi: 10.1097/WAD.0000000000000622.
    >> Share

  2. BRIGGS AQ, Ouedraogo Tall S, Boza-Calvo C, Bernard MA, et al
    Drivers of Memory Loss Underreport in Mild Cognitive Impairment Due to Alzheimer Versus Vascular Disease.
    Alzheimer Dis Assoc Disord. 2024 May 17. doi: 10.1097/WAD.0000000000000627.
    >> Share

  3. HAGHDEL A, Smith N, Glodzik L, Li Y, et al
    Evidence of Pericyte Damage in a Cognitively Normal Cohort: Association With CSF and PET Biomarkers of Alzheimer's Disease.
    Alzheimer Dis Assoc Disord. 2024 May 16. doi: 10.1097/WAD.0000000000000623.
    >> Share

  4. TERESI JA, Ocepek-Welikson K, Eimicke JP, Ramirez M, et al
    Measurement of Allostatic Load in Caregivers of Older Hispanic People With Alzheimer Disease and Related Disorders.
    Alzheimer Dis Assoc Disord. 2024 May 16. doi: 10.1097/WAD.0000000000000625.
    >> Share


    Alzheimers Dement

  5. MELCHER EM, Vilen L, Pfaff A, Lim S, et al
    Deriving life-course residential histories in brain bank cohorts: A feasibility study.
    Alzheimers Dement. 2024;20:3219-3227.
    >> Share

  6. CORONEL-OLIVEROS C, Gomez RG, Ranasinghe K, Sainz-Ballesteros A, et al
    Viscous dynamics associated with hypoexcitation and structural disintegration in neurodegeneration via generative whole-brain modeling.
    Alzheimers Dement. 2024;20:3228-3250.
    >> Share

  7. JONAITIS EM, Hermann BP, Mueller KD, Clark LR, et al
    Longitudinal normative standards for cognitive tests and composites using harmonized data from two Wisconsin AD-risk-enriched cohorts.
    Alzheimers Dement. 2024;20:3305-3321.
    >> Share

  8. QIU T, Liu ZQ, Rheault F, Legarreta JH, et al
    Structural white matter properties and cognitive resilience to tau pathology.
    Alzheimers Dement. 2024;20:3364-3377.
    >> Share

  9. CHEN T, O'Gorman J, Castrillo-Viguera C, Rajagovindan R, et al
    Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab.
    Alzheimers Dement. 2024;20:3406-3415.
    >> Share

  10. CHO S, Olm CA, Ash S, Shellikeri S, et al
    Automatic classification of AD pathology in FTD phenotypes using natural speech.
    Alzheimers Dement. 2024;20:3416-3428.
    >> Share

  11. BOLLACK A, Collij LE, Garcia DV, Shekari M, et al
    Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study.
    Alzheimers Dement. 2024;20:3429-3441.
    >> Share

  12. XHIMA K, Ottoy J, Gibson E, Zukotynski K, et al
    Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology.
    Alzheimers Dement. 2024;20:3687-3695.
    >> Share

  13. PETKUS AJ, Wang X, Younan D, Salminen LE, et al
    20-year depressive symptoms, dementia, and structural neuropathology in older women.
    Alzheimers Dement. 2024;20:3472-3484.
    >> Share

  14. AHMED C, Greve HJ, Garza-Lombo C, Malley JA, et al
    Peripheral HMGB1 is linked to O(3) pathology of disease-associated astrocytes and amyloid.
    Alzheimers Dement. 2024;20:3551-3566.
    >> Share

  15. KOTREDES KP, Pandey RS, Persohn S, Elderidge K, et al
    Characterizing molecular and synaptic signatures in mouse models of late-onset Alzheimer's disease independent of amyloid and tau pathology.
    Alzheimers Dement. 2024 May 12. doi: 10.1002/alz.13828.
    >> Share

  16. SUCHY-DICEY AM, Domoto-Reilly K, Nelson L, Jayadev S, et al
    Epidemiology and prevalence of dementia and Alzheimer's disease in American Indians: Data from the Strong Heart Study.
    Alzheimers Dement. 2024 May 15. doi: 10.1002/alz.13849.
    >> Share

  17. KWAPONG WR, Tang F, Liu P, Zhang Z, et al
    Choriocapillaris reduction accurately discriminates against early-onset Alzheimer's disease.
    Alzheimers Dement. 2024 May 15. doi: 10.1002/alz.13871.
    >> Share

  18. RUDOLPH MD, Sutphen CL, Register TC, Whitlow CT, et al
    Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health-related comorbidities in a community-dwelling cohort.
    Alzheimers Dement. 2024 May 15. doi: 10.1002/alz.13835.
    >> Share

  19. BROWN C, Das S, Xie L, Nasrallah I, et al
    Medial temporal lobe gray matter microstructure in preclinical Alzheimer's disease.
    Alzheimers Dement. 2024 May 15. doi: 10.1002/alz.13832.
    >> Share

  20. HOU Y, Chu X, Park JH, Zhu Q, et al
    Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions.
    Alzheimers Dement. 2024 May 16. doi: 10.1002/alz.13847.
    >> Share

  21. ZHANG Y, Ferreira PCL, Jacobsen E, Bellaver B, et al
    Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population-based study.
    Alzheimers Dement. 2024 May 16. doi: 10.1002/alz.13829.
    >> Share

  22. ADKINS-JACKSON PB, Kraal AZ, Hill-Jarrett TG, George KM, et al
    Riding the merry-go-round of racial disparities in ADRD research.
    Alzheimers Dement. 2023;19:4735-4742.
    >> Share

  23. KAPASI A, Yu L, Leurgans SE, Agrawal S, et al
    Association between hippocampal microglia, AD and LATE-NC, and cognitive decline in older adults.
    Alzheimers Dement. 2024;20:3193-3202.
    >> Share

  24. MEYER MR, Kirmess KM, Eastwood S, Wente-Roth TL, et al
    Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Abeta42/40 ratio to identify presence of brain amyloid.
    Alzheimers Dement. 2024;20:3179-3192.
    >> Share

  25. HILLERSTROM H, Fisher R, Janicki MP, Chicoine B, et al
    Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome.
    Alzheimers Dement. 2024;20:3649-3656.
    >> Share

  26. HE K, Li B, Wang J, Wang Y, et al
    APOE epsilon4 is associated with decreased synaptic density in cognitively impaired participants.
    Alzheimers Dement. 2024;20:3157-3166.
    >> Share


    Am J Geriatr Psychiatry

  27. SHAW JS, Leoutsakos JM, Rosenberg PB
    The Relationship Between First Presenting Neuropsychiatric Symptoms in Older Adults and Autopsy-Confirmed Memory Disorders.
    Am J Geriatr Psychiatry. 2024;32:754-764.
    >> Share

  28. GALLET Q, Bouteloup V, Locatelli M, Habert MO, et al
    Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older Adults: An FDG-PET Study in the MEMENTO Cohort.
    Am J Geriatr Psychiatry. 2024;32:665-677.
    >> Share


    Ann Neurol

  29. CHEN XQ, Becker A, Albay R, Nguyen PD, et al
    gamma-Secretase Modulator BPN15606 Reduced Abeta42 and Abeta40 and Countered Alzheimer-Related Pathologies in a Mouse Model of Down Syndrome.
    Ann Neurol. 2024 May 15. doi: 10.1002/ana.26958.
    >> Share

  30. HARRISON TM, Chadwick T, Pezzoli S, Lee J, et al
    Cognitive Trajectories and Alzheimer Disease Biomarkers: From Successful Cognitive Aging to Clinical Impairment.
    Ann Neurol. 2024 May 15. doi: 10.1002/ana.26964.
    >> Share

  31. KANAZAWA T, Sato W, Raveney BJE, Takewaki D, et al
    Pathogenic Potential of Eomesodermin-Expressing T-Helper Cells in Neurodegenerative Diseases.
    Ann Neurol. 2024;95:1093-1098.
    >> Share


    BMC Neurosci

  32. LEE CY, Riffle D, Xiong Y, Momtaz N, et al
    Characterizing dysregulations via cell-cell communications in Alzheimer's brains using single-cell transcriptomes.
    BMC Neurosci. 2024;25:24.
    >> Share


    Brain

  33. CHEN F, Zhao J, Meng F, He F, et al
    The vascular contribution of apolipoprotein E to Alzheimer's disease.
    Brain. 2024 May 15:awae156. doi: 10.1093.
    >> Share

  34. SOCH J, Richter A, Kizilirmak JM, Schutze H, et al
    Single-value brain activity scores reflect both severity and risk across the Alzheimer's continuum.
    Brain. 2024 May 14:awae149. doi: 10.1093.
    >> Share

  35. BLUM D, Levi S
    Targeting excitatory:inhibitory network imbalance in Alzheimer's disease.
    Brain. 2024 May 13:awae146. doi: 10.1093.
    >> Share


    Brain Res

  36. FU Y, Xie GM, Liu RQ, Xie JL, et al
    From aberrant neurodevelopment to neurodegeneration: Insights into the hub gene associated with autism and alzheimer's disease.
    Brain Res. 2024;1838:148992.
    >> Share


    Exp Gerontol

  37. AKBARI M, Moardi S, Piri H, Amiri R, et al
    The identification of active compounds and therapeutic properties of fermented and non-fermented red sorghum for the treatment of Alzheimer's dementia.
    Exp Gerontol. 2024;192:112459.
    >> Share


    Exp Neurol

  38. BARATI N, Shojaeian A, Ramezani M, Kalhori F, et al
    Investigating the effect of parasites (toxoplasma gondii RH strain, Leishmania major (MRHO/IR/75/ER), and hydatid cyst) antigens on Alzheimer's disease: An in vivo evaluation.
    Exp Neurol. 2024;377:114813.
    >> Share


    J Alzheimers Dis

  39. PLUTA R, Bogucka-Kocka A, Bogucki J, Kocki J, et al
    Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer's Disease with 2-Year Survival.
    J Alzheimers Dis. 2024 May 16. doi: 10.3233/JAD-240401.
    >> Share

  40. KURIHARA M, Kondo S, Ohse K, Nojima H, et al
    Relationship Between Cerebrospinal Fluid Alzheimer's Disease Biomarker Values Measured via Lumipulse Assays and Conventional ELISA: Single-Center Experience and Systematic Review.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-240185.
    >> Share

  41. ZENG B, Tang C, Wang J, Yang Q, et al
    Pharmacologic and Nutritional Interventions for Early Alzheimer's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    J Alzheimers Dis. 2024 May 17. doi: 10.3233/JAD-240161.
    >> Share

  42. MCINTIRE LB
    Prognostic Power? Do the Plasma Biomarkers, Neurofilament Light and Phospho-Tau 181, Improve Prediction of Progression to Alzheimer's Disease Using a Machine Learning Approach in the ADNI Cohort?
    J Alzheimers Dis. 2024 May 14. doi: 10.3233/JAD-240126.
    >> Share

  43. WU C, Ruan T, Yuan Y, Xu C, et al
    Alterations in Synaptic Connectivity and Synaptic Transmission in Alzheimer's Disease with High Physical Activity.
    J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-240123.
    >> Share

  44. WEGNER P, Balabin H, Ay MC, Bauermeister S, et al
    Semantic Harmonization of Alzheimer's Disease Datasets Using AD-Mapper.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-240116.
    >> Share

  45. IRFAN B, Ankouni G, Reader J, Seraji-Bozorgzad N, et al
    Alzheimer's Disease and Related Dementias in Muslim Women: Recommendations for Culturally Sensitive Care.
    J Alzheimers Dis. 2024 May 13. doi: 10.3233/JAD-240064.
    >> Share

  46. COSTANTINI E, Carrarini C, Calisi D, De Rosa M, et al
    Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 16. doi: 10.3233/JAD-231471.
    >> Share

  47. SATO K, Niimi Y, Ihara R, Suzuki K, et al
    Simplifying Alzheimer's Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities Questionnaire.
    J Alzheimers Dis. 2024 May 11. doi: 10.3233/JAD-231426.
    >> Share

  48. NAKAYA M, Sato N, Matsuda H, Maikusa N, et al
    Assessment of Gray Matter Microstructural Alterations in Alzheimer's Disease by Free Water Imaging.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-231416.
    >> Share

  49. CHONG JSX, Tan YJ, Koh AJ, Ting SKS, et al
    Plasma Neurofilament Light Relates to Divergent Default and Salience Network Connectivity in Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia.
    J Alzheimers Dis. 2024 May 11. doi: 10.3233/JAD-231251.
    >> Share

  50. ZAKRZEWSKI JJ, Davis JD, Gemelli ZT, Korthauer LE, et al
    Understanding Health Beliefs and Health Behaviors in Older Adults at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 13. doi: 10.3233/JAD-230977.
    >> Share

  51. STAM CJ, de Haan W
    Network Hyperexcitability in Early-Stage Alzheimer's Disease: Evaluation of Functional Connectivity Biomarkers in a Computational Disease Model.
    J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-230825.
    >> Share


    J Am Geriatr Soc

  52. ARELLANES I, Mirsafian L, Wang Y, Jacobson M, et al
    Reporting and representation of participant demographic information in completed Alzheimer's disease clinical trials.
    J Am Geriatr Soc. 2024 May 15. doi: 10.1111/jgs.18958.
    >> Share


    J Neurosci

  53. LIU Y, Kwok W, Yoon H, Ryu JC, et al
    Imbalance in Glucose Metabolism Regulates the Transition of Microglia from Homeostasis to Disease-Associated Microglia Stage 1.
    J Neurosci. 2024;44:e1563232024.
    >> Share


    Lancet Neurol

  54. KAPASI A, Schneider JA
    Speculation on the transmissibility of Alzheimer's disease.
    Lancet Neurol. 2024;23:555-556.
    >> Share


    Nat Med

  55. SHANKS HRC, Chen K, Reiman EM, Blennow K, et al
    p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial.
    Nat Med. 2024 May 17. doi: 10.1038/s41591-024-02977.
    >> Share


    Nat Rev Neurol

  56. KIANI L
    Genetic protection against Alzheimer disease.
    Nat Rev Neurol. 2024 May 14. doi: 10.1038/s41582-024-00968.
    >> Share


    Neurobiol Dis

  57. CANET G, Gratuze M, Zussy C, Bouali ML, et al
    Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice.
    Neurobiol Dis. 2024 May 9:106526. doi: 10.1016/j.nbd.2024.106526.
    >> Share


    Neurosci Lett

  58. CHEN W, Zhang T, Zhang H
    Genes related to neurotransmitter receptors as potential biomarkers for Alzheimer's disease.
    Neurosci Lett. 2024;832:137816.
    >> Share


    PLoS One

  59. ABUAWAD M, Rjoub A, Dumaidi Y, Daraghma M, et al
    Evaluation of knowledge and attitudes regarding Alzheimer's disease and related dementia among medical students in Palestine: A cross-sectional study.
    PLoS One. 2024;19:e0304012.
    >> Share

  60. BURKE JF, Copeland LL, Sussman JB, Hayward RA, et al
    Development and validation of the Michigan Chronic Disease Simulation Model (MICROSIM).
    PLoS One. 2024;19:e0300005.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016